Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
774.70
Change Change %
-21.25 -2.67%

Updated:13 Nov, 2018, 15:58 PM IST

BSE
774.70
Change Change %
-23.60 -2.96%

Updated:13 Nov, 2018, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Bank of America Merrill Lynch
N/A
15-07-2014 Buy 688.30 880.00
N/A
Target Hit Long (1Y)
15-07-2015

Bank of America Merrill Lynch maintains buy on Aurobindo Pharma

Aurobindo Pharma has aspirations to be a $3 billion drugmaker by FY17. Actavis buy will dilute some margins. Company is doing R&D investment of $150-200 million for niche portfolio.

Top